The CBER Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics (BEST 3)

Award Notice Posted

Solicitation number
FDA-SOL-1224068
Agency
Awarded
Set-aside
No set-aside

Opportunity facts

Contract number
See_Contracts_Below
Place of performance
USA

Notice details come from SAM.gov. Updated .

About this opportunity

This multiple award ID/IQ contract from the FDA's CBER provides data sources for post-market biologics surveillance. Three contractors were awarded IDIQ ceilings of $50 million each, with $10,000 minimum guarantees. The Lewin Group, IQVIA Government Solutions, and Aetna/Healthagen will support the BEST Initiative #3 in providing data and analytics to monitor the safety and effectiveness of biologics, as issued by the Department of Health and Human Services' FDA.

Notice text

Multiple Award Indefinite Delivery / Indefinite Quantity (ID/IQ) contract for the Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics (BEST 3).

$50,000,000.00 IDIQ ceiling for each contract. $10,000 minimum guarantee for each contract.

Awardees:

1) The Lewin Group, Inc.

3160 Fairview Park Dr STE 600

Falls Church VA 22042-4516

Contract:

75F40120D00026

Award date: 9/30/20

2) IQVIA Government Solutions, Inc.

3110 Fairview Park DR STE 400

Falls Church VA 22042-4503

75F40120D00027

Award date: 9/29/20

3) AETNA INC. / Healthagen LLC

3160 151 Farmington Ave.

Hartford CT 06156-000175

F40120D00028

Award date: 9/29/20

Awarded contract See_Contracts_Below to See Below for 50000000.00 on 2020-09-30.

Notice history

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors